Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.

International journal of cancer - 1 May 2009

Murphy Gwen, Cross Amanda J, Sansbury Leah S, Bergen Andrew, Laiyemo Adeyinka O, Albert Paul S, Wang Zhuoqiao, Yu Binbing, Lehman Teresa, Kalidindi Aravind, Modali Rama, Schatzkin Arthur, Lanza Elaine

Abstract excerpt

Epidemiological evidence suggests that obesity may be causally associated with colorectal cancer. Dopamine and the dopaminergic reward pathway have been implicated in drug and alcohol addiction as well as obesity. Polymorphisms within the D2 dopamine receptor gene (DRD2) have been shown to be ass...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma
Share to Alcohol Drinking
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Neoplasm Recurrence, Local

Share to Receptors, Dopamine D2

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 19065655
DOI: 10.1002/ijc.24079
PMCID: PMC2768275

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19065655-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.PMID 19065655Read ↗

Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.Semantic proximity Read ↗

CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence.Semantic proximity Read ↗

Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.Semantic proximity Read ↗

Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.Semantic proximity Read ↗

Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.Semantic proximity Read ↗

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.Semantic proximity Read ↗

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.Semantic proximity Read ↗

Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.Semantic proximity Read ↗

Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.Semantic proximity Read ↗

MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.Semantic proximity Read ↗

Polynucleotide kinase 3' phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial.Semantic proximity Read ↗

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.